Physician Wealth Advisors’s Praxis Precision Medicines PRAX Stock Holding History

Physician Wealth Advisors’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.67K	Buy	5 +1	+25%	+$317	﹤0.01%	1578
2026 Q1	$1.29K	Buy	+4	New	+$1.24K	﹤0.01%	1545
2025 Q2	–	Sell	-17	Closed	-$644	–	1937
2025 Q1	$644	Buy	+17	New	+$1.06K	﹤0.01%	1313

Other funds holding PRAX

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Physician Wealth Advisors's PRAX Position: Q2 2026 in Review

Physician Wealth Advisors increased its Praxis Precision Medicines (PRAX) stake by 25% in Q2 2026, buying an estimated $317 and bringing the position to 5 shares worth $1.67K. The position accounts for ﹤0.01% of the portfolio, ranked #1578.

Physician Wealth Advisors first reported a position in PRAX in Q1 2025 and has held it in 3 quarters since. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

Physician Wealth Advisors held 5 shares of Praxis Precision Medicines worth $1.67K as of Q2 2026.
Physician Wealth Advisors bought 1 Praxis Precision Medicines share in Q2 2026, an estimated $317.
Praxis Precision Medicines made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #1578 holding.
Physician Wealth Advisors first reported a position in Praxis Precision Medicines in Q1 2025 and has held it in 3 quarters since.
310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.